In contrast, expression of miR-495 (a putative regulator of CDK6 expression) is low in glioma tumor tissues, whereas its over-expression appears to block or delay the G1/S transition of the cell cycle by downregulating CDK6, thus inhibiting proliferation of malignant glioma cells. This evidence concerns the gene CDK6 and malignant glioma.